Vitality and various partner organizations with contributions from the board of the European Society of Preventive Medicine, released Guidelines for Personalized Health Technology: Final Report. The proposed guidelines are principles for the responsible innovation of personalized health technologies – devices such as wearables, smartwatches, and mobile health applications – and the appropriate stewardship of data from these technologies. The guidelines are:
- Build health technologies informed by science
- Scale affordable health technologies
- Guide interpretation of health data
- Protect and secure health data
- Govern the responsible use of health technology and data
The guidelines follow the publication of an open-access, peer-reviewed commentary by colleagues at Vitality, Microsoft, and The Qualcomm Institute at the University of California, San Diego. This article called for a public consultation to identify best practices to eliminate ethical, legal, and social barriers to personalized health technologies. For 90 days between July and October 2015, a wide range of stakeholders offered input on a draft set of guidelines. Feedback came from organizations such as the EU Commission, the US Food and Drug Administration, the National Academy of Medicine, and the American Heart Association. Private sector companies also offered their input.